site stats
Back

HepQuant

HepQuant is a clinical laboratory with headquarters in Denver and a CLIA lab in Aurora, Colorado. We recently launched our first Laboratory Developed Test (LDT) to the US market. HepQuant develops non-invasive, quantitative tests that measure liver health. The HepQuant DuO test enables healthcare providers to manage patients with liver diseases more effectively. It delivers information about liver cell function and portal-systemic shunting, attributes of liver disease that are associated with clinical outcomes. Results may be used by a physician in conjunction with clinical evaluation and other tests to aid in the decision to proceed with or defer invasive procedures, to monitor treatment response, or to predict disease progression and adverse outcomes, such as ascites, encephalopathy, and variceal bleeding.

May 02, 2026
Full time
Key Account Manager (KAM) – Texas
HepQuant TX
Job Duties HepQuant is seeking a highly motivated Key Account Manager (KAM) to support the growth of the HepQuant DuO® liver health test across Texas. This field-based role is responsible for driving adoption and utilization of HepQuant’s innovative diagnostic solutions by building strong relationships with hepatologists, advanced practice providers (APPs), and other key stakeholders. The KAM will work cross-functionally with internal teams to ensure a seamless customer experience and represent HepQuant at targeted industry events. Responsibilities •Promote and expand adoption of the HepQuant DuO® liver health test among hepatologists, advanced practice providers, and other key customers throughout Texas •Develop and manage key accounts, building long-term relationships and serving as a trusted partner to clinical and administrative stakeholders •Collaborate effectively with internal teams including commercial, medical affairs, and market access to align strategies and...
May 02, 2026
Full time
Medical Science Liaison-Hepatology/Gastroenterology- Western US
HepQuant Western, NE
About Us HepQuant has developed noninvasive, blood-based, quantitative tests that assess liver health by measuring critical liver cell processes and blood flow to the liver. Our test results support healthcare providers’ clinical decisions to achieve more effective management of patients with advanced liver disease. HepQuant DuO testing delivers a Disease Severity Index (DSI), assessing a patient’s current level of liver impairment and disease state. Results may be used by health care providers in conjunction with other clinical assessment to aid in the decision to defer invasive procedures or to evaluate a patient’s risk for clinical complications and disease progression. Job Duties The Medical Science Liaison (MSL) is a field-based role focused on developing and maintaining professional relationships with key medical experts and decision makers as they relate to HepQuant products. As a member of this important function, this individual will help design programs to drive...